Association of Neoadjuvant Chemotherapy With Overall Survival in Women With Metastatic Endometrial Cancer
Sign Up to like & getrecommendations! Published in 2020 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2020.28612
Abstract: This cohort study uses data from the National Cancer Database to investigate the association of neoadjuvant therapy with overall survival in women with metastatic endometrial cancer. read more here.
Keywords: association neoadjuvant; survival women; metastatic endometrial; cancer ... See more keywords
Anlotinib in recurrent or metastatic endometrial cancer
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Gynecological Cancer"
DOI: 10.1136/ijgc-2022-003345
Abstract: Objective For recurrent or metastatic endometrial cancer after second-line treatment, therapeutic options are limited. Anlotinib is a new multi-targeted tyrosine kinase inhibitor of tumor angiogenesis and growth. The aim of this study was to explore… read more here.
Keywords: endometrial cancer; cancer; survival; rate ... See more keywords
A rapidly evolving landscape: immune checkpoint inhibitors in pretreated metastatic endometrial cancer
Sign Up to like & getrecommendations! Published in 2023 at "Therapeutic Advances in Medical Oncology"
DOI: 10.1177/17588359231157633
Abstract: Background and objectives: Endometrial cancer is a common malignancy and recurrences can be fatal. Although platinum-pretreated endometrial tumors are commonly treated with anthracyclines and taxanes, there is no current standard of care. Both immune checkpoint… read more here.
Keywords: endometrial cancer; cancer; checkpoint inhibitors; immune checkpoint ... See more keywords